packagePralatrexate

pralatrexate

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pralatrexate is an anticancer drug, a folate analogue antimetabolite, used to treat mature T-cell and NK-cell lymphoma. It is approved in the United States, but a marketing application for the European Union was refused, so it is not authorised in the EU.

Summary written by glm-5.3-flash from Wikidata Q637059 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pralatrexate
ATC codes:L01BA05
DrugBank:DB06813
PubChem CID:148121
ChEBI:71223
Wikidata:Q637059
formula:C23H23N7O5
molar mass:477.481 g/mol (PubChem CID 148121)
logP:-0.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown